Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Patients With Active Illicit Substance usE

Clinical trial NCT03998176 · COMPLETED

Trial details

NCT number: NCT03998176
Sponsor: University of Nebraska
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2019-10-09
Primary completion: 2021-10-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.